TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for ...

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Connected Drug Delivery Devices Market (3rd Edition): Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area & ...

An in-depth analysis of completed and ongoing clinical trials related to connected drug delivery devices, during the time period pre-2011-2020, based on several relevant parameters, such as trial ...

Embecta Corp. EMBC recently announced a definitive agreement to acquire Owen Mumford Holdings Limited, a pioneer in ...

CINCINNATI (WKRC) - A new wearable drug delivery device made by Enable Injections in Evendale could soon help change the lives of those living with a progressive disorder that impacts the nervous ...

Tell us about Teva’s recent combination device approvals. Teva received approval for Uzedy which is a long acting risperidone to treat schizophrenia. For this drug, Teva was looking for a way to ...

What work are you leading at Merck KGaA? My role is to help Merck develop drug delivery systems used to administer our injectable medicines. We have a variety of devices, including disposable and ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/066303/the_drug_delivery) has announced the addition of the "The Drug ...

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more ...

(MENAFN- GlobeNewsWire - Nasdaq) The connected drug delivery market is poised for growth driven by rising chronic diseases, enhanced patient compliance, and telehealth adoption. Key opportunities lie ...